This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of INFUVITE PEDIATRIC VIAL 5ML. The contract has a ceiling value of $16,121.10 and an ultimate completion date of August 5, 2024. It is a firm-fixed-price contract, with no set-aside designation. Amerisourcebergen has been a significant supplier of pharmaceutical products and medical supplies to various federal agencies, including...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of INFUVITE PEDIATRIC VIAL 5ML, a medical product, with a period of performance through July 2, 2025 and a ceiling value of $20,090.52. The contract is structured as a firm fixed-price delivery order and does not have a set-aside designation, indicating open competition....
This is a delivery order contract awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA) for INFUVITE PEDIATRIC VIAL 5ML. The contract has a ceiling value of $26,480.58 and runs through July 24, 2024. It is a firm-fixed-price contract with no set-aside requirements. Amerisourcebergen, a for-profit organization, holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical valued at $999,999,999 through...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation's Corporate Office division. The $1,645.94 firm fixed-price contract is for the delivery of INFUVITE PEDIATRIC VIAL 5ML, a pharmaceutical product. This order does not have a set-aside designation. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, including military treatment facilities, veterans' hospitals, and other...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract is for the supply of INFUVITE ADULT VIAL 10ML, a medical product, with a ceiling value of $6,413.18 and a period of performance through April 30, 2025. This contract is not set aside and is a firm fixed-price delivery order. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of INFUVITE ADULT VIAL 10ML. The contract has a ceiling value of $4,999.10 and a performance period extending through May 15, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999.00 that AmerisourceBergen holds with the DLA Troop Support Medical, which provides a comprehensive global...
This is a federal delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of INFUVITE ADULT VIAL 10ML medical products. The contract has a ceiling value of $2,597.96 and a period of performance through May 8, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a comprehensive...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,348.42 contract is for the supply of INFUVITE PEDIATRIC VIAL 5ML, a pharmaceutical product. The award has an ultimate completion date of October 28, 2024 and is a firm fixed-price delivery order contract. The contract is not designated as a set-aside. AmerisourceBergen holds a $999,999,999 Indefinite Delivery...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The $1,320.00 contract is for the delivery of INFUVITE PEDIATRIC BULK VIAL 50ML, a pharmaceutical product, with a performance period through March 14, 2024. AmerisourceBergen Drug Corp holds an indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through December 31, 2025, which serves as the primary vehicle...
This is a firm fixed price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation. The $25,964.76 contract is for the delivery of 4563728634 INFUVITE PEDIATRIC VIAL 5ML medical products to be completed by February 22, 2024. Amerisourcebergen Drug Corp, a for-profit organization, holds an indefinite delivery contract (IDC) with DLA valued up to $999,999,999.00 through December 31, 2025 to provide a...